
Opinion|Videos|July 23, 2026
Pharmacist-Led Toxicity Management in Menin Inhibitor Therapy
In this episode, Ali outlines the non-negotiable items on the first-fill consultation checklist, including baseline ECG requirements, medication review for drug interactions, and enrollment in manufacturer support programs.
Advertisement
Episodes in this series

In this episode, Ali outlines the non-negotiable items on the first-fill consultation checklist, including baseline ECG requirements, medication review for drug interactions, and enrollment in manufacturer support programs. He provides detailed counseling guidance on differentiation syndrome—the class-defining toxicity—and explains what action thresholds cross the line from monitoring to intervention.
Advertisement
Related to this article

In more than 262,000 UK Biobank participants, a 5-marker cardiometabolic score was linked to graded risk at each step toward CKM multimorbidity.

Two IDWeek 2026 studies link influenza vaccination to fewer ICU admissions in older adults and fewer emergency visits in children.

The approval offers a once-weekly basal insulin treatment option for patients, reducing the frequency of injections.

Early data suggest the 7 PCV20-added serotypes are causing a smaller share of invasive pneumococcal disease in children younger than 2 years.

In pooled CORALreef data, patients with eGFR below 60 had a 65.9% placebo-adjusted LDL-C reduction at week 24, with safety comparable to placebo.

A PharmD candidate reflects on the small, evidence-backed daily habits that helped her thrive—not just survive—through pharmacy school's most demanding years.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Bepirovirsen, First ASO for Chronic Hepatitis B
2
Operationalizing Therapy and Managing Hypophosphatemia Risk at UPMC
3
CagriSema Tied to 25% Weight Loss in Women, Post Hoc Data Show
4
Kidney Week 2026: What to Know for Nephrology's Biggest Meeting
5


